Skip to main content

STERIS plc cash flow statement

  • STE · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$264.32+4.29%Close 13 Nov 2026

In fiscal 2026 (the year to 31 Mar 2026), STERIS plc generated $1.34B of operating cash flow and $972.4M of free cash flow, after $369.0M of capital expenditure.

From STERIS plc's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Mar 2026. TTM is the last four reported quarters added up.

Annual

STERIS plc cash flow statement, annual
USDFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Net income$110.0M$290.9M$303.7M$407.7M$397.4M$243.9M$107.0M$378.2M$614.6M$782.3M$826.9M
Depreciation & amortization$188.1M$178.3M$225.9M$197.2M$219.2M$553.1M$552.9M$565.2M$476.2M$486.5M$494.8M
Stock-based compensation$18.79M$22.19M$23.96M$23.81M$25.97M$57.66M$38.95M$56.50M$57.40M$61.70M$63.10M
Operating cash flow$424.1M$457.6M$539.5M$590.6M$689.6M$684.8M$756.9M$973.3M$1.15B$1.34B$1.29B
Operating cash flow margin16.2%17.5%19.4%19.5%22.2%16.2%16.7%18.9%21.0%22.6%20.9%
Capital expenditures$172.9M$165.5M$189.7M$214.5M$239.3M$287.6M$362.0M$360.3M$370.1M$369.0M$352.5M
Acquisitions$65.56M$46.27M$13.31M$109.8M$909.2M$550.4M$42.57M$546.3M$54.10M$20.10M$21.10M
Free cash flow$251.2M$292.2M$349.8M$376.0M$450.4M$397.2M$395.0M$613.0M$778.0M$972.4M$937.2M
Free cash flow margin9.6%11.2%12.6%12.4%14.5%9.4%8.7%11.9%14.3%16.4%15.2%
Free cash flow per share$2.92$3.41$4.09$4.39$5.24$4.04$3.94$6.17$7.85$9.85$9.55
Dividends paid$93.19M$102.9M$112.5M$123.0M$133.8M$163.2M$183.5M$200.6M$219.9M$241.8M$252.1M
Gross share repurchases$97.51M$65.48M$81.49M$51.24M$14.65M$55.78M$308.6M$11.80M$211.3M$235.5M$340.3M
Stock issuance proceeds$4.96M$11.09M$13.31M$34.73M$26.73M$10.07M$1.83M$10.50M$25.50M$32.90M$21.80M
Net share repurchases$92.55M$54.39M$68.19M$16.51M−$12.08M$45.71M$306.7M$1.30M$185.8M$202.6M$318.5M
Cash interest paid$42.80M$48.66M$44.12M$38.02M$36.26M$84.70M$108.5M$142.2M$89.40M$64.70M—
Free cash flow after SBC$232.4M$270.0M$325.8M$352.2M$424.4M$339.6M$356.0M$556.5M$720.6M$910.7M$874.1M

Quarterly

STERIS plc cash flow statement, quarterly
USDQ3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027Q2 FY2027
Net income$140.7M−$1.38M$145.4M$150.0M$173.5M$145.6M$177.4M$191.9M$192.9M$220.2M$200.1M$213.7M
Depreciation & amortization$140.6M$134.4M$112.7M$115.3M$125.9M$122.3M$119.4M$121.7M$122.0M$123.4M$123.8M$125.6M
Stock-based compensation$15.29M$8.95M$11.50M$20.80M$15.30M$9.80M$11.90M$21.20M$15.70M$12.90M$12.80M$21.70M
Operating cash flow$291.2M$254.8M$303.7M$250.8M$332.8M$260.8M$420.0M$287.8M$298.2M$335.4M$367.1M$289.0M
Operating cash flow margin22.4%18.0%23.7%18.9%24.3%17.6%30.2%19.7%19.9%21.1%24.6%18.2%
Capital expenditures$118.9M$91.50M$108.1M$101.9M$89.20M$70.89M$93.60M$86.50M$98.70M$90.20M$87.50M$76.10M
Acquisitions$0.00$6.54M$13.70M$3.80M$36.20M$400.0K$15.00M$0.00$5.10M$0.00$16.00M$0.00
Free cash flow$172.3M$163.3M$195.6M$148.9M$243.6M$189.9M$326.4M$201.3M$199.5M$245.2M$279.6M$212.9M
Free cash flow margin13.3%11.5%15.3%11.2%17.8%12.8%23.5%13.8%13.3%15.4%18.7%13.4%
Free cash flow per share$1.73$1.64$1.97$1.50$2.46$1.92$3.30$2.04$2.02$2.49$2.86$2.18
Dividends paid$51.38M$51.40M$51.40M$56.30M$56.20M$55.98M$56.20M$61.90M$61.90M$61.80M$61.40M$67.00M
Gross share repurchases$2.23M$360.0K$64.20M$46.42M$100.5M$200.0K$10.60M$100.5M$50.10M$74.30M$115.5M$100.4M
Stock issuance proceeds$786.0K$6.97M$5.60M$13.50M$300.0K$6.07M$9.30M$7.60M$15.40M$600.0K$1.30M$4.50M
Net share repurchases$1.44M−$6.61M$58.60M$32.92M$100.2M−$5.87M$1.30M$92.90M$34.70M$73.70M$114.2M$95.90M
Free cash flow after SBC$157.0M$154.4M$184.1M$128.1M$228.3M$180.1M$314.5M$180.1M$183.8M$232.3M$266.8M$191.2M

The main figures as JSON and plain text. See data and methodology.

STE in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.